• Skip to main content
  • Skip to primary sidebar

Tracking Health and Wellness Applications of Brain Science

Spanish
sb-logo-with-brain
  • Resources
    • Monthly eNewsletter
    • Solving the Brain Fitness Puzzle
    • The SharpBrains Guide to Brain Fitness
    • How to evaluate brain training claims
    • Resources at a Glance
  • Brain Teasers
    • Top 25 Brain Teasers & Games for Teens and Adults
    • Brain Teasers for each Cognitive Ability
    • More Mind Teasers & Games for Adults of any Age
  • Virtual Summits
    • 2019 SharpBrains Virtual Summit
    • Speaker Roster
    • Brainnovations Pitch Contest
    • 2017 SharpBrains Virtual Summit
    • 2016 SharpBrains Virtual Summit
    • 2015 SharpBrains Virtual Summit
    • 2014 SharpBrains Virtual Summit
  • Report: Pervasive Neurotechnology
  • Report: Digital Brain Health
  • About
    • Mission & Team
    • Endorsements
    • Public Speaking
    • In the News
    • Contact Us

AI-enabled chatbot Wysa receives FDA Breakthrough Device designation for patients with chronic pain, depression and anxiety

June 6, 2022 by SharpBrains Leave a Comment

AI Behav­ior Health Chat­bot App Fast-Tracked by FDA (Psy­chol­o­gy Today):

Recent­ly the U.S. Food and Drug Admin­is­tra­tion (FDA) grant­ed break­through device des­ig­na­tion to Wysa’s AI-based dig­i­tal men­tal health con­ver­sa­tion­al agent that deliv­ers cog­ni­tive behav­ioral ther­a­py (CBT) via a smart­phone to adults suf­fer­ing from depres­sion, anx­i­ety, and chron­ic mus­cu­loskele­tal pain…

Wysa’s admit­tance to the FDA Break­through Devices Pro­gram sig­ni­fies a giant leap for­ward for arti­fi­cial intel­li­gence in the men­tal health indus­try. Accord­ing to the FDA, the des­ig­na­tion was sup­port­ed by a clin­i­cal tri­al that “found Wysa to be more effec­tive than stan­dard ortho­pe­dic care and com­pa­ra­ble to in-per­son psy­cho­log­i­cal coun­sel­ing” … The study authors affil­i­at­ed with the Wash­ing­ton Uni­ver­si­ty in St Louis School of Med­i­cine in St Louis, Mis­souri, and the Uni­ver­si­ty of Wash­ing­ton in Seat­tle, Wash­ing­ton, wrote:

  • Patients who received a dig­i­tal men­tal health inter­ven­tion as part of ortho­pe­dic care report­ed greater two-month mean improve­ments in depres­sion, pain inter­fer­ence, and phys­i­cal func­tion than patients who received usu­al ortho­pe­dic care.
  • They also report­ed a greater mean improve­ment in phys­i­cal func­tion and com­pa­ra­ble improve­ments in depres­sion, anx­i­ety, and pain inter­fer­ence com­pared with ortho­pe­dic patients who received in-per­son psy­cho­log­i­cal counseling.

The Announcement:

Wysa Receives FDA Break­through Device Des­ig­na­tion for AI-led Men­tal Health Con­ver­sa­tion­al Agent (press release):

Wysa, a lead­ing arti­fi­cial intel­li­gence (AI) based dig­i­tal com­pan­ion for behav­ioral health, has announced that the U.S. Food and Drug Admin­is­tra­tion (FDA) has grant­ed Break­through Device Des­ig­na­tion for its AI-based dig­i­tal men­tal health con­ver­sa­tion­al agent for patients 18 years and old­er with a diag­no­sis of chron­ic mus­cu­loskele­tal pain (defined as pain last­ing longer than three months) and depres­sion and anxiety.

The device deliv­ers cog­ni­tive behav­ioral ther­a­py (CBT) via a smart­phone-based con­ver­sa­tion­al agent to reduce the symp­toms of depres­sion and anx­i­ety, reduce pain inter­fer­ence, and improve phys­i­cal function.

The des­ig­na­tion fol­lows an inde­pen­dent peer reviewed clin­i­cal tri­al, pub­lished in JMIR, that found Wysa to be effec­tive for man­ag­ing chron­ic pain and asso­ci­at­ed depres­sion and anx­i­ety, which was found to be more effec­tive than stan­dard ortho­pe­dic care, and com­pa­ra­ble to in-per­son psy­cho­log­i­cal counseling.

News in Context:

  • Arti­fi­cial Intel­li­gence (AI)-enabled chat­bot Wysa rais­es $5.5M to broad­en access to men­tal health support
  • A call to action: We need the right incen­tives to guide eth­i­cal inno­va­tion in neu­rotech and healthcare
  • The Nation­al Acad­e­my of Med­i­cine (NAM) shares dis­cus­sion paper to help empow­er 8 bil­lion minds

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Brain/ Mental Health, Technology & Innovation Tagged With: anxiety, artificial intelligence, CBT, chronic musculoskeletal pain, cognitive-behavioral-therapy, depression, digital mental health, FDA, Food and Drug Administration, mental health industry, smartphone, Wysa

Reader Interactions

Leave a Reply Cancel reply

Primary Sidebar

Top Articles on Brain Health and Neuroplasticity

  1. Can you grow your hippocampus? Yes. Here’s how, and why it matters
  2. How learning changes your brain
  3. To harness neuroplasticity, start with enthusiasm
  4. Three ways to protect your mental health during –and after– COVID-19
  5. Why you turn down the radio when you're lost
  6. Solving the Brain Fitness Puzzle Is the Key to Self-Empowered Aging
  7. Ten neu­rotech­nolo­gies about to trans­form brain enhance­ment & health
  8. Five reasons the future of brain enhancement is digital, pervasive and (hopefully) bright
  9. What Educators and Parents Should Know About Neuroplasticity and Dance
  10. The Ten Habits of Highly Effective Brains
  11. Six tips to build resilience and prevent brain-damaging stress
  12. Can brain training work? Yes, if it meets these 5 conditions
  13. What are cognitive abilities and how to boost them?
  14. Eight Tips To Remember What You Read
  15. Twenty Must-Know Facts to Harness Neuroplasticity and Improve Brain Health

Top 10 Brain Teasers and Illusions

  1. You think you know the colors? Try the Stroop Test
  2. Check out this brief attention experiment
  3. Test your stress level
  4. Guess: Are there more brain connections or leaves in the Amazon?
  5. Quick brain teasers to flex two key men­tal mus­cles
  6. Count the Fs in this sentence
  7. Can you iden­tify Apple’s logo?
  8. Ten classic optical illu­sions to trick your mind
  9. What do you see?
  10. Fun Mental Rotation challenge
  • Check our Top 25 Brain Teasers, Games and Illusions

Join 35,341 readers exploring, at no cost, the latest in neuroplasticity and brain health.

By subscribing you agree to receive our free, monthly eNewsletter. We don't rent or sell emails collected, and you may unsubscribe at any time.

IMPORTANT: Please check your inbox or spam folder in a couple minutes and confirm your subscription.

Get In Touch!

Contact Us

660 4th Street, Suite 205,
San Francisco, CA 94107 USA

About Us

SharpBrains is an independent market research firm tracking health and performance applications of brain science. We prepare general and tailored market reports, publish consumer guides, produce an annual global and virtual conference, and provide strategic advisory services.

© 2022 SharpBrains. All Rights Reserved - Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.